The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

First-of-Its-Kind Diabetic Retinopathy Treatment Approved Roche’s Susvimo is now the first and only FDA-approved continuous ...

Basel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

A single intravitreal injection of UBX1325 (foselutoclax), a novel senolytic small molecule inhibitor, had a tolerable safety profile and "trends suggestive of potential efficacy" in patients with ...

In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...

Researcher works with universities of California-Davis, Illinois, Wisconsin and others to engineer and test a novel microsphere-hydrogel delivery for medicine, requiring fewer injections, to treat a c ...